Trajan announces landmark collaboration in R&D and manufacturing with Australian academia and government

Melbourne, Australia: Trajan Scientific and Medical (Trajan) continues to expand their technical and research capabilities, announcing a landmark agreement with academia and government in Australia today.

Trajan’s latest strategic collaboration with the University of Adelaide, supported by the South Australian Government, sees the realization of a research and development and manufacturing hub based on a new generation of specialty glass products for the global science and medical equipment market.

The hub will help scientists in the University’s Institute for Photonics and Advanced Sensing (IPAS) and the School of Physical Sciences commercialize their research into products that ultimately benefit human health and wellbeing.

The products have the potential to be utilized in a wide range of medical and scientific applications including genetic testing, biomarker discovery and detection, environmental analysis, food safety testing, testing for drugs of abuse and therapeutic drug monitoring.

Chief Executive Officer of Trajan, Stephen Tomisich says Trajan’s goal is for the hub to become a global center of excellence for advanced photonics technologies.

“I anticipate that, through Trajan’s ability to present the world class photonics capabilities on the global stage, there will be many additional flow-on benefits. Partnering with Trajan essentially enables the commercialization of IPAS research discoveries, ensuring our work is applied to real-world situations – a hugely exciting outcome with almost unlimited potential,” Mr Tomisich said.

Professor Mike Brooks, Deputy Vice-Chancellor (Research), University of Adelaide adds: “Trajan’s skills in advanced manufacturing – including processes and systems, quality control, and logistics – combined with our research expertise and facilities, will enable transition of research outputs from the University and its partners into commercial manufacturing.”

Trajan’s global operations and customer base, partnered with the international standing IPAS enjoys as a center of excellence in photonics and specialty glass technologies, means this collaboration will provide an incredible global platform to promote Australia.

Trajan’s focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements – especially those that can lead to portability, miniaturization and affordability.

Trajan Scientific and Medical

Trajan collaborates with academic and industry partners to develop and deliver innovative products. Together we will deliver breakthrough solutions to improve human wellbeing through biological, environmental or food related measurements.

Our focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific – especially those that can lead to portability, miniaturization and affordability.

A 17,000 m2 Ringwood site in Melbourne, Victoria, is home to Trajan’s corporate headquarters and ISO accredited manufacturing operations. With over 300 staff worldwide across Australia, Europe, USA and Asia, Trajan serves customers in over 100 countries with highly specialized consumables and components used in scientific analysis and clinical applications.

IPAS

The Institute for Photonics and Advanced Sensing (IPAS) fosters excellence in research in materials science, chemistry, biology and physics and develops disruptive new tools for measurement.

A global hub of Photonics research, IPAS is one of 5 research institutes at The University of Adelaide, and holds links with companies and Universities on almost every continent. The 185 researchers at IPAS develop novel photonic, sensing and measurement technologies that are creating new tools for scientific research and stimulating the creation of new industries.

About Trajan Scientific and Medical

Trajan aspires to bring together a range of global businesses in the fields of scientific and medical analysis that have a common bond; to focus on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements, especially those that can lead to portability, miniaturization and affordability.

Trajan, formed in 2011, has a global presence with around 300 staff worldwide, with headquarters in Melbourne, Australia and significant operations in the USA, Europe and Japan.

In October 2011, Trajan acquired the pathology consumables business of Grale Scientific (Victoria, Australia). In June 2013, Grale Scientific acquired the consumables business of HD Scientific (New South Wales, Australia) to become a new entity, Grale HDS.

In May 2013, Trajan acquired the Chromatography and Liquid Handling businesses of SGE Analytical Science, since its foundation in 1960 has become a leader in creating components and consumables used in scientific analysis.

< | >